Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New vascular damaging agents in development at Angiogene Pharmaceuticals

April 9, 2002

WX-G250 and WX-G250RIT designated orphan drugs for renal cell carcinoma in E.U.

April 9, 2002

Inhibitors of uPA with favorable PK properties described in patent literature

April 9, 2002

Preclinical data discussed this week support clinical trials with thioplatin

April 9, 2002

European Commission designates E21R orphan drug in JMML

April 9, 2002

Adherex and AstraZeneca extend Exherin collaboration agreement

April 9, 2002

Independent review and long-term follow-up of phase II Orathecin study

April 9, 2002

Orally active VEGF receptor tyrosine kinase-selective agent presented at AACR meeting

April 9, 2002

Favorable pharmacokinetic profile seen for novel tyrosine kinase inhibitor CHIR-200131

April 9, 2002

Flt-3 kinase inhibitors and potential for treatment of AML discussed in Orlando by Millennium

April 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...